周日夜盘，诺瓦瓦克斯医药（NVAX）股价出现显著上涨，涨幅达5.44%，引发市场关注。这一涨势似乎与美国总统特朗普最新宣布的药品定价政策有关。
据报道，特朗普在其社交媒体上宣布，他将于北京时间周一21点在白宫签署一项具有深远影响的行政命令。这项命令旨在大幅降低美国的处方药和药品价格，预计降幅将在30%至80%之间。特朗普表示，这一政策将实施"最惠国"原则，使美国支付与世界上药价最低国家相同的价格。
虽然这一政策可能对整个制药行业产生广泛影响，但诺瓦瓦克斯医药股价的上涨表明投资者对该公司在新政策下的前景持乐观态度。可能的原因包括：公司产品定价策略具有竞争力，或者其市场地位有望在新的定价环境中得到加强。然而，具体影响还有待进一步观察和分析。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.